|
CONSUMER NEWS RECALLS COMPLAINT FORM SCAM ALERTS |
| Small Claims Guide | Class Actions | Lemon Law | FAQ | Resources | Newsletters | Spanish | |
|
|
|
HEALTH:
Intro |
Health Clubs |
Hearing Aids |
Malpractice |
Nursing Homes |
Nutrition |
Rx |
Vision Care |
Weight Loss
|
New Hope for Breast Cancer |
|||||||
|
By Henry J. Fishman, M.D. October 28, 2005
HER-2 is a gene that produces a protein that helps the cancer spread. Herceptin blocks the protein and according to an article published in the New England Journal of Medicine the drug does a good job blocking it. About 3,200 women with HER-2 positive cancer underwent surgery and chemotherapy. Afterwards, half received Herceptin every 3 weeks for about 8 months and half did not. Hercpetin cut the recurrence rate and the rate of new cancers and death nearly in half. Now to be fair, Herceptin did rarely cause congestive heart failure and we don’t know its long-term consequences. We also don’t know if it should be given along with rather than after chemotherapy. Still, women with HER-2 positive breast cancer should talk with their doctors about Herceptin. Report Your Experience
|
|
|||||
Advertisement
|
Home |
Rogues Gallery |
Good Guys |
Complaint Form |
News |
Recalls |
Search |
Video |
FAQ |
|
Terms of Use Your use of this site constitutes acceptance of the Terms of Use
Copyright © 2003-2008 ConsumerAffairs.com Inc. All Rights Reserved. |